US Patent 9108944 Androgen receptor modulators and uses thereof
Patent 9108944 was granted and assigned to Aragon Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+394 characters)
Article
Patent abstract
Described herein are compounds that are androgen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such androgen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon androgen receptors.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09108944 Androgen receptor modulators and uses thereof US Patent 9108944 Androgen receptor modulators and uses thereof
Infobox
Patent Number
091089440
Patent Number
91089440
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091089440
Date of Patent
August 18, 2015
0Patent Application Number
135790090
Date Filed
February 16, 2011
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09108944 Androgen receptor modulators and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09108944
Date of patent
August 18, 2015
Patent application number
13579009
Date Filed
February 16, 2011
Patent primary examiner
Find more entities like US Patent 9108944 Androgen receptor modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.